about
Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes.Copper in diseases and treatments, and copper-based anticancer strategies.Advances in copper complexes as anticancer agents.The combined therapeutical effect of metal-based drugs and radiation therapy: the present status of research.Novel triazolium based 11(th) group NHCs: synthesis, characterization and cellular response mechanisms.In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes.The relationship between electrospray ionization behavior and cytotoxic activity of [M(I)(P)4](+)-type complexes (M = Cu, Ag and Au; P = tertiary phosphine).Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity.Novel metalloantimalarials: Transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei.Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors.Sulfonate- or carboxylate-functionalized N-heterocyclic bis-carbene ligands and related water soluble silver complexes.Variable coordination modes of NO2(-) in a series of Ag(I) complexes containing triorganophosphines, -arsines, and -stibines. Syntheses, spectroscopic characterization (IR, 1H and 31P NMR, electrospray ionization mass), and structures of [AgNO2(R(3)Crystal structures and vibrational and solution and solid-state (CPMAS) NMR spectroscopic studies in triphenyl phosphine, arsine, and stibine silver(I) bromate systems, (R3E)xAgBrO3 (E = P, As, Sb; x = 1-4).Silver(I) and copper(I) complexes supported by fully fluorinated 1,3,5-triazapentadienyl ligands.The first nitro-substituted heteroscorpionate ligand.Insights into the cytotoxic activity of the phosphane copper(I) complex [Cu(thp)4][PF6].Silver(I)-organophosphane complexes of electron withdrawing CF3- or NO2-substituted scorpionate ligands.Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.New insights in Au-NHCs complexes as anticancer agents.Halide and nitrite recognizing hexanuclear metallacycle copper(II) pyrazolates.The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor.Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)₄][PF₆] with methionine-rich model peptides.Synthesis, spectroscopic characterization (IR,1H,13C and119Sn NMR, electrospray mass spectrometry) and toxicity of new organotin(IV) complexes withN,N′,O- andN,N′,S-scorpionate ligandsSynthesis, characterization and crystal structure of new copper(II) complexes with tris- and tetrakis-(pyrazol-1-yl)borate ligandsRole of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells.Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications.Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands.Small scorpionate ligands: silver(I)-organophosphane complexes of 5-CF(3)-substituted scorpionate ligand combining a B-H...Ag coordination motifA study on the coordinative versatility of new N,S-donor macrocyclic ligands: XAFS, and Cu2+ complexation thermodynamics in solutionTrinuclear copper(I) complexes with triscarbene ligands: catalysis of C-N and C-C coupling reactionsNitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studiesSyntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu(I) and Cu(II) complexesSynthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist
P50
Q35565660-E40DBE9C-50E8-477A-B40B-3622775C641CQ36010027-E50B87EA-1013-48BE-92A0-C86D4A86D3A3Q37559436-89513D89-92BB-4E32-8EBC-1CD1387FF9F8Q38150409-1D3382A2-0D29-4115-BE96-5A7B73DFAA1BQ38188630-2BCA10F1-E1C1-4DAA-8151-BFEF898D248FQ38818120-C30A5ACC-FEE5-49B7-AD09-01FC123C6926Q38998872-9A5A8AC3-5231-4DC0-B871-439626BC178FQ39079825-11458A2B-6646-4DE7-AB95-D8B044C5B629Q39111089-E9CC15D0-CCFA-4D8A-B74C-C3E530826053Q39228517-B22E3E25-107C-4E0D-885B-ACA1FB2077B7Q39613622-772AA26D-327E-4822-813E-795CD5D06B5FQ40016313-B6096BBD-E28F-49A5-8DF2-99EA5B225C00Q40043661-5620BA6B-6239-4CB6-8699-5E8B4E653F81Q40334858-EA11D5A5-0634-4782-B007-250E04C4AD06Q40462929-1B5B78CC-3F99-4FF9-9C42-7CF50C192BABQ42635176-00B77DCD-699D-4649-BF1E-CBDA8DF573B6Q43070995-D61AA821-8CF4-4EA2-8CA0-D7FD492CEBE8Q44241248-94D1E484-8C9A-4694-8C6A-5C60925C1174Q44535087-5A9411D2-3C69-49F7-BA05-CA6F36B61CA4Q45174871-61C7165F-9EA5-4F70-AF39-C4A067D9ACC5Q46461951-C90AB66E-4394-478C-85AC-44F8E638FD06Q46512408-A9C0F00E-4E02-45F6-AAFF-CD2F42C32A90Q46936492-5443B168-6D77-4098-9D0D-E67F8A2D6325Q47712025-C81085DA-A7D7-44A6-908E-DA9ED9118BF3Q50171113-21EBF8A2-A3EC-4A0B-BB56-20F72E66DF38Q50439230-D4378772-9DBF-42F6-99B4-94BC10AC958EQ51444482-24A52D1A-A0AD-4C0B-8002-B8475F0EBEDFQ52821400-461B14B7-9F46-4522-A31C-09CADC9924A3Q59566094-A6D8E495-BF44-4BA6-BFA4-B8AB01CBEF10Q60219871-571F84A1-803D-4857-96AE-ED6F2AE3A97AQ64911312-D8E614E8-5EAB-4EC0-A26A-7085A2197C3CQ64917322-8226FAAC-A986-48A0-A160-4DC1D467309DQ64957058-6BAE5D1F-1764-4A6E-A091-547318E1E16DQ81413103-631EACDA-0F2B-4193-868E-EB89B34E182CQ83379861-40E727C5-2952-4D81-8D5C-995F196DFFA2Q84178125-5C8940C0-DEC2-4FE4-9064-BA2A8293D2B5Q84458162-5CC7C66B-8463-4B84-82D4-5A56C6187853Q90573953-6AFE6CA7-5FD2-4E51-AAF6-C56814EC689CQ91869003-A5D0836D-8F69-4929-B8E9-B8565C93DEAA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlo Santini
@ast
Carlo Santini
@en
Carlo Santini
@es
Carlo Santini
@nl
Carlo Santini
@sl
type
label
Carlo Santini
@ast
Carlo Santini
@en
Carlo Santini
@es
Carlo Santini
@nl
Carlo Santini
@sl
prefLabel
Carlo Santini
@ast
Carlo Santini
@en
Carlo Santini
@es
Carlo Santini
@nl
Carlo Santini
@sl
P1053
R-2268-2016
P106
P1153
57208256944
7004397550
P1960
zuVcY-wAAAAJ
P21
P31
P3829
P3835
carlo-santini
P496
0000-0002-3942-1713